Stem Cell Network (SCN)
2022-2025 Research Funding Competition
The Stem Cell Network (SCN) is pleased to launch a new multimillion-dollar national research funding competition to support world-class, translational, regenerative medicine research, across the research continuum, to facilitate health, social and economic benefits for Canadians.
This new competition will open Wednesday, September 1, 2021 and support research activities during the 2022 to 2025 time period. Seven regenerative medicine research programs will be available that focus on career development, innovation, clinical translation, policy and societal impact, commercialization and transformative technology development.
The seven programs available are:
Early Career Researcher Jump Start Awards: SCN will provide up to $300,000 for early career researchers (within the first five years of an initial academic appointment) to develop a research program with a regenerative medicine focus.
Impact Awards: SCN will provide up to $250,000 to support proof-of-principle experiments, including novel therapeutic or technical approach development that will drive regenerative medicine therapies forward.
Clinical Trial Awards: SCN will provide up to $1,000,000 to support early-stage clinical trial projects with high translational potential.
Translation & Society Teams Award: SCN will provide up to $750,000 to support high-calibre ELSI research teams to undertake innovative, high-impact research that facilitates regenerative medicine for the benefit of society.
Knowledge Translation Awards: SCN will provide up to $200,000 to support the knowledge translation of regenerative medicine research for targeted stakeholders and/or users.
Fueling Biotechnology Partnerships Awards: SCN will provide up to $400,000 to support academic partnerships with emerging Canadian regenerative medicine biotechnology companies to bring innovative technologies or therapies to the clinic or market.
Horizon Awards: SCN will provide up to $3,000,000 to fuel national multi-disciplinary teams focused on developing transformative technology solutions for tackling significant regenerative medicine challenges.
Please see the program-specific eligibility criteria in each program's Guidelines Document found on the 2022-2025 Research Funding Competition's website.
Early Career Researcher Jump Start Awards: Up to $300,000.
Impact Awards: Up to $250,000.
Clinical Trial Awards: Up to $1,000,000.
Translation & Society Teams Award: Up to $750,000.
Knowledge Translation Awards: Up to $200,000.
Fueling Biotechnology Partnerships Awards: Up to $400,000.
Horizon Awards: Up to $3,000,000.
Maximum Project Value
See funding availability.
Indirect costs and PI salaries are not eligible for funding
This new competition will open Wednesday, September 1, 2021 and support research activities during the 2022 to 2025 time period.
Funding is dependent on the completion of Stem Cell Network’s 2022-2025 contribution agreement with the Government of Canada.
Please note that research activities carried out in the context of COVID-19 need to adhere to the University of Guelph COVID-19 research principles, policies, guidelines and processes as they may be updated from time to time and communicated on the Office of Research web-page.
If College-level review is required, your College will communicate its earlier internal deadlines.
Letter of Intent (LOI) submissions open.
Letter of intent (LOI) submission deadline.
Full application submission deadline.
How to Apply
A letter of Intent (LOI) submission is mandatory for all Stem Cell Network funding programs. LOI and full application-related questions should be addressed to Rebecca Cadwalader at firstname.lastname@example.org.
Researchers interested in learning more about this new Stem Cell Network funding competition, including the available programs, and the application process, are invited to participate in an online technical briefing webinar on Tuesday, August 17, 2021, at 1 p.m. ET. Registration can be accessed through the Webinar Registration Page.